Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 14;24(3):178–189. doi: 10.1089/dia.2021.0319

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Anders L. Carlson, et al., 2022; Published by Mary Ann Liebert, Inc.

This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

PMC Copyright notice

FIG. 4. — SG and insulin delivered profiles, during the run-in period and study phase. The median and IQRs of SG levels (top panel) and the units of insulin delivered during the run-in period (middle panel) and study phase (bottom panel), across the 24-h day for the overall, adolescent (14–21 years), and adult (>21–75 years) groups are shown. For SG, medians (solid), and IQR intervals (dotted) of the run-in period (gray) and study phase (pink) appeared to vary most during the nighttime period (12 AM–6 AM). For insulin delivered, the units of total basal (blue), user-initiated bolus (orange), and automated correction bolus (gray) are shown. The study phase Auto Correction bolus averaged 20% of total bolus for all groups. System use during the run-in period included SAP, PLGM, or Auto Basal therapy, whereas that for the study phase included Auto Basal and Auto Correction. During baseline run-in period, Auto Correction bolus was inadvertently delivered on six systems. IQRs, interquartile ranges; SG, sensor glucose.